4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
申请人:MacDonald Gregor James
公开号:US08906921B2
公开(公告)日:2014-12-09
The present invention relates to (1-benzyl-piperidin-4-yl)-(4-alkoxy-pyridazin-3-y1)-amines that are fast dissociating dopamine 2 receptor antagonists, processes for preparing these compounds, pharmaceutical compositions comprising these compounds as an active ingredient. The compounds find utility as medicines for treating or preventing central nervous system disorders, for example schizophrenia, by exerting an antipsychotic effect without motor side effects.
本发明涉及(1-苄基哌啶-4-基)-(4-烷氧基吡啶并[3,2-d]嗪-1-基)-胺,这些化合物是快速解离的多巴胺2受体拮抗剂,制备这些化合物的方法,包含这些化合物作为活性成分的制药组合物。这些化合物可用于治疗或预防中枢神经系统疾病,例如精神分裂症,通过发挥抗精神病作用而不产生运动副作用。